These results suggest that the secretory pathway of hSOD1 differs from that of endogenous murine SOD1 and that the hSOD1 pathway is inhibited when the ALS-causing hSOD1 mutants are intracellularly expressed. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.